+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Australia Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Nicotine Replacement Therapy, E-Cigarettes), Distribution Channel (Online, Offline), and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 119 Pages
  • December 2023
  • Region: Australia, Global
  • Grand View Research
  • ID: 5921089
The Australia nicotine replacement therapy market size is projected to reach USD 226.74 million by 2030, and is anticipated to register a CAGR of 4.10% from 2024 to 2030, according to the study. Increasing emphasis on smoking cessation programs coupled with growing awareness about the ill effects of tobacco consumption are expected to fuel the market growth during the forecast period.

Smoking cessation laws and campaigns are also playing a crucial role in increasing awareness about diseases caused due to smoking. For instance, in September 2023, the Australian Government introduced tobacco control legislation in the parliament to fight against nicotine and tobacco addiction. In addition, global organizations such as the World Health Organization are also working toward creating awareness by running online campaigns. Public health campaigns employ powerful imagery and real-life stories to vividly convey the health risks associated with smoking. Healthcare professionals play a pivotal role by discussing the links between smoking and severe illnesses with patients. Schools integrate anti-smoking messages into their curricula, emphasizing the impact of smoking on health, social life, and future prospects.

Furthermore, according to a study published by the Australian Institute of Health and Welfare in 2023, people aged 40 years and above are likely to smoke 20+ cigarettes per day in the country. However, after understanding its negative impact on health, people are opting for cessation therapies. For instance, according to a study published by the government of Australia in 2023, the volume of cigarettes consumed in 2023 was much less than in 2017. Australia increasingly emphasized smoking cessation as a significant public health priority. The country recognizes the profound impact of tobacco use on individual health & the broader healthcare system. As part of its commitment to reducing smoking rates, Australia has implemented a multifaceted approach.

However, a stringent regulatory framework for the sale and marketing of NRT products is expected to act as a restraint to the market. The use of e-cigarettes is highly regulated and restricted for certain applications. For instance, the utilization of e-cigarettes containing nicotine requires a mandatory prescription. Australia's regulatory stance on nicotine-containing products has undergone changes and adjustments to achieve a balance for promoting harm reduction & addressing public health concerns. The regulations aim to provide clarity and accountability while also acknowledging the potential benefits of harm-reduction strategies for smokers.

Australia Nicotine Replacement Therapy Market Report Highlights

  • Based on product, the nicotine replacement therapy segment held the largest revenue share in 2023 owing to the lucrative subsidies, product availability, and innovative products. Furthermore, industry developments such as distribution agreements are also projected to offer a favorable environment for segment growth
  • Based on distribution channel, the offline segment dominated the market in 2023. Substantial emphasis of the people to get advice about nicotine replacement therapy products and buying convenience are estimated to drive offline segment growth during the forecast period
  • The online distribution channel segment in the Australia NRT market is expected to witness considerable growth due to consumer preferences, user-friendly platforms, faster shipping, and optimum prices


This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1. Market Segmentation
1.2. Market Definitions
1.3. Objectives
1.3.1 Objective - 1
1.3.2 Objective - 2
1.3.3 Objective - 3
1.4. Research Methodology
1.4.1 Information Procurement
1.4.2 Purchased Database
1.4.3 Internal database
1.4.4 Secondary Sources
1.4.5. Primary Research
1.5 Information Or Data Analysis
1.5.1. Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.8 Commodity Flow Analysis
1.8.1 List Of Secondary Sources
1.8.2 List Of Abbreviations
1.8.3 List Of Primary Sources
Chapter 2 Executive Summary
2.1 Market And Product Segment Snapshot
2.2 Distribution Channel Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Australia Nicotine Replacement Therapy Market Variables, Trends, And Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Technological Advancements
3.2.1.2 Rise In Awareness About Ill Effects Of Smoking
3.2.1.3 Rising Number Of People Undergoing Smoking Cessation
3.2.2 Market Restraint Analysis
3.2.2.1 Stringent Regulatory Framework
3.3 Regulatory Scenario
3.4 Epidemiology Analysis
3.5 Business Environment Analysis
3.5.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.5.2 Industry Analysis - Porter’s
Chapter 4 Australia Nicotine Replacement Therapy Market - Segment Analysis, By Product, 2018-2030 (USD Million)
4.1 Australia Nicotine Replacement Therapy Market: Product Movement Analysis
4.2 Australia Nicotine Replacement Therapy Market Estimates & Forecast, By Product (USD Million)
4.2.1 Nicotine Replacement Therapy
4.2.1.1 Inhalers
4.2.1.2 Gum
4.2.1.3 Transdermal Patches
4.2.1.4 Sublingual Tablets
4.2.1.5 Lozenges
4.2.1.6 Others
4.2.2 E-cigarettes
4.2.3 Heat-not-burn Tobacco Products
Chapter 5 Australia Nicotine Replacement Therapy Market - Segment Analysis, By Distribution Channel, 2018-2030 (USD Million)
5.1 Australia Nicotine Replacement Therapy Market: Distribution Channel Movement Analysis
5.2 Australia Nicotine Replacement Therapy Market Estimates & Forecast, By Distribution Channel (USD Million)
5.2.1 Online
5.2.2 Offline
5.2.2.1 Hospital Pharmacies
5.2.2.2 Retail Pharmacies
5.2.2.3 Others (Supermarkets & Other Modes)
Chapter 6 Australia Nicotine Replacement Therapy Market - Competitive Landscape
6.1 Participant’s Overview
6.2 Financial Performance
6.3 Participant Categorization
6.3.1 Market Leaders
6.3.2 Market Share Analysis, 2023
6.3.3 Company Profiles
6.3.3.1 Philip Morris Products S.A. (Altria Group)
6.3.3.1.1 Company Overview
6.3.3.1.2 Financial Performance
6.3.3.1.3 Product Benchmarking
6.3.3.1.4 Strategic Initiatives
6.3.3.2 British American Tobacco P.L.C.
6.3.3.2.1 Company Overview
6.3.3.2.2 Financial Performance
6.3.3.2.3 Product Benchmarking
6.3.3.2.4 Strategic Initiatives
6.3.3.3 Haleon Group Of Companies
6.3.3.3.1 Company Overview
6.3.3.3.2 Financial Performance
6.3.3.3.3 Product Benchmarking
6.3.3.3.4 Strategic Initiatives
6.3.3.4 Johnson & Johnson Services, Inc.
6.3.3.4.1 Company Overview
6.3.3.4.2 Financial Performance
6.3.3.4.3 Product Benchmarking
6.3.3.4.4 Strategic Initiatives
6.3.3.5 Liber Pharmaceuticals Pty Ltd
6.3.3.5.1 Company Overview
6.3.3.5.2 Financial Performance
6.3.3.5.3 Product Benchmarking
6.3.3.5.4 Strategic Initiatives
6.3.3.6 Philip Morris Products S.A. (Altria Group)
6.3.3.6.1 Company Overview
6.3.3.6.2 Financial Performance
6.3.3.6.3 Product Benchmarking
6.3.3.6.4 Strategic Initiatives
6.3.3.7 Alphapharm Pty Limited
6.3.3.7.1 Company Overview
6.3.3.7.2 Financial Performance
6.3.3.7.3 Product Benchmarking
6.3.3.7.4 Strategic Initiatives
6.3.3.8 Perrigo Company Plc
6.3.3.8.1 Company Overview
6.3.3.8.2 Financial Performance
6.3.3.8.3 Product Benchmarking
6.3.3.8.4 Strategic Initiatives
6.3.3.9 Amcal
6.3.3.9.1 Company Overview
6.3.3.9.2 Financial Performance
6.3.3.9.3 Product Benchmarking
6.3.3.9.4 Strategic Initiatives
6.3.3.10 GAK Plc
6.3.3.10.1 Company Overview
6.3.3.10.2 Financial Performance
6.3.3.10.3 Product Benchmarking
6.3.3.10.4 Strategic Initiatives
Chapter 7 Conclusion
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Australia nicotine replacement therapy market revenue estimates and forecasts, by product, 2018-2030 (USD Million)
Table 4 Australia nicotine replacement therapy market revenue estimates and forecasts, by distribution channel, 2018-2030 (USD Million)
List of Figures
Figure 1 Australia Nicotine Replacement Therapy Market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain based sizing & forecasting
Figure 7 QFD modelling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market and product segment snapshot
Figure 10 Distribution channel segment snapshot
Figure 11 Competitive landscape snapshot
Figure 12 Market dynamics
Figure 13 Status of daily smokers - Australia (1991-2023)
Figure 14 Trend in incidence of lung cancer (2000-2023)
Figure 15 SWOT analysis, by factor (Political & legal, economic, and technological)
Figure 16 Industry analysis - Porter’s
Figure 17 Australia nicotine replacement therapy market: Product outlook and key takeaways
Figure 18 Australia nicotine replacement therapy market: Product movement analysis
Figure 19 Nicotine replacement therapy market estimates and forecast, 2018-2030 (USD Million)
Figure 20 Inhalers market estimates and forecast, 2018-2030 (USD Million)
Figure 21 Gum market estimates and forecast, 2018-2030 (USD Million)
Figure 22 Transdermal patches market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Sublingual tablets market estimates and forecast, 2018-2030 (USD Million)
Figure 24 Lozenges market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 26 E-cigarettes market estimates and forecast, 2018-2030 (USD Million)
Figure 27 Australia nicotine replacement therapy market: Distribution channel outlook and key takeaways
Figure 28 Australia nicotine replacement therapy market: Distribution channel movement analysis
Figure 29 Online market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Offline market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Hospital pharmacies market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Retail pharmacies market estimates and forecast, 2018-2030 (USD Million)
Figure 33 Others (supermarkets & other modes) market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Market participant categorization
Figure 35 Australia nicotine replacement therapy market share analysis, 2022

Companies Mentioned

  • Philip Morris Products S.A. (Altria Group)
  • British American Tobacco P.L.C.
  • Haleon Group Of Companies
  • Johnson & Johnson Services, Inc.
  • Liber Pharmaceuticals Pty Ltd
  • Philip Morris Products S.A. (Altria Group)
  • Alphapharm Pty Limited
  • Perrigo Company Plc
  • Amcal
  • GAK Plc

Methodology

Loading
LOADING...

Table Information